p2xFLAGhYAP1 Citations (11)

Originally described in: WW domain-containing protein YAP associates with ErbB-4 and acts as a co-transcriptional activator for the carboxyl-terminal fragment of ErbB-4 that translocates to the nucleus.
Komuro A, Nagai M, Navin NE, Sudol M J Biol Chem. 2003 Aug 29. 278(35):33334-41. PubMed Journal

---

Articles Citing p2xFLAGhYAP1

Articles
The Hippo pathway member Yap plays a key role in influencing fate decisions in muscle satellite cells. Judson RN, Tremblay AM, Knopp P, White RB, Urcia R, De Bari C, Zammit PS, Camargo FD, Wackerhage H. J Cell Sci. 2012 Dec 15;125(Pt 24):6009-19. doi: 10.1242/jcs.109546. Epub 2012 Oct 4. PubMed
Yes-associated protein (YAP) is a negative regulator of chondrogenesis in mesenchymal stem cells. Karystinou A, Roelofs AJ, Neve A, Cantatore FP, Wackerhage H, De Bari C. Arthritis Res Ther. 2015 May 30;17:147. doi: 10.1186/s13075-015-0639-9. PubMed
Optimal myelin elongation relies on YAP activation by axonal growth and inhibition by Crb3/Hippo pathway. Fernando RN, Cotter L, Perrin-Tricaud C, Berthelot J, Bartolami S, Pereira JA, Gonzalez S, Suter U, Tricaud N. Nat Commun. 2016 Jul 20;7:12186. doi: 10.1038/ncomms12186. PubMed
Sphingosylphosphorylcholine regulates the Hippo signaling pathway in a dual manner. Kemppainen K, Wentus N, Lassila T, Laiho A, Tornquist K. Cell Signal. 2016 Dec;28(12):1894-1903. doi: 10.1016/j.cellsig.2016.09.004. Epub 2016 Sep 12. PubMed
YAP regulates cell mechanics by controlling focal adhesion assembly. Nardone G, Oliver-De La Cruz J, Vrbsky J, Martini C, Pribyl J, Skladal P, Pesl M, Caluori G, Pagliari S, Martino F, Maceckova Z, Hajduch M, Sanz-Garcia A, Pugno NM, Stokin GB, Forte G. Nat Commun. 2017 May 15;8:15321. doi: 10.1038/ncomms15321. PubMed
Common and Distinctive Functions of the Hippo Effectors Taz and Yap in Skeletal Muscle Stem Cell Function. Sun C, De Mello V, Mohamed A, Ortuste Quiroga HP, Garcia-Munoz A, Al Bloshi A, Tremblay AM, von Kriegsheim A, Collie-Duguid E, Vargesson N, Matallanas D, Wackerhage H, Zammit PS. Stem Cells. 2017 Aug;35(8):1958-1972. doi: 10.1002/stem.2652. Epub 2017 Jun 27. PubMed
Force Triggers YAP Nuclear Entry by Regulating Transport across Nuclear Pores. Elosegui-Artola A, Andreu I, Beedle AEM, Lezamiz A, Uroz M, Kosmalska AJ, Oria R, Kechagia JZ, Rico-Lastres P, Le Roux AL, Shanahan CM, Trepat X, Navajas D, Garcia-Manyes S, Roca-Cusachs P. Cell. 2017 Nov 30;171(6):1397-1410.e14. doi: 10.1016/j.cell.2017.10.008. Epub 2017 Oct 26. PubMed
A RASSF1A-HIF1alpha loop drives Warburg effect in cancer and pulmonary hypertension. Dabral S, Muecke C, Valasarajan C, Schmoranzer M, Wietelmann A, Semenza GL, Meister M, Muley T, Seeger-Nukpezah T, Samakovlis C, Weissmann N, Grimminger F, Seeger W, Savai R, Pullamsetti SS. Nat Commun. 2019 May 13;10(1):2130. doi: 10.1038/s41467-019-10044-z. PubMed
AMOTL1 enhances YAP1 stability and promotes YAP1-driven gastric oncogenesis. Zhou Y, Zhang J, Li H, Huang T, Wong CC, Wu F, Wu M, Weng N, Liu L, Cheng ASL, Yu J, Wong N, Lo KW, Tang PMK, Kang W, To KF. Oncogene. 2020 May;39(22):4375-4389. doi: 10.1038/s41388-020-1293-5. Epub 2020 Apr 20. PubMed
RASSF1A-Mediated Suppression of Estrogen Receptor Alpha (ERalpha)-Driven Breast Cancer Cell Growth Depends on the Hippo-Kinases LATS1 and 2. Rosswag S, Sleeman JP, Thaler S. Cells. 2021 Oct 24;10(11). pii: cells10112868. doi: 10.3390/cells10112868. PubMed
RASSF1A disrupts the NOTCH signaling axis via SNURF/RNF4-mediated ubiquitination of HES1. Papaspyropoulos A, Angelopoulou A, Mourkioti I, Polyzou A, Pankova D, Toskas K, Lanfredini S, Pantazaki AA, Lagopati N, Kotsinas A, Evangelou K, Chronopoulos E, O'Neill E, Gorgoulis V. EMBO Rep. 2022 Feb 3;23(2):e51287. doi: 10.15252/embr.202051287. Epub 2021 Dec 13. PubMed

If you have published an article using this material, please email us at to have your article added to this page.